Evidence map›Paper›PMID 21157431›Full record

ArticleThe EMBO journal2011

ATM activates the pentose phosphate pathway promoting anti-oxidant defence and DNA repair.

Claudia Cosentino, Domenico Grieco, Vincenzo Costanzo

Registry-linked trialOpen access · bronzeAbstract read
In one paragraph

Article in The EMBO journal, 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT02345200 (Body Composition, Muscle Strength and Hormonal Status in Patients With Ataxia Telangiectasia Compared to Healthy Controls), which is not on this map. Cited by 245 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
245citing papers in PubMed, 1 pooled it
11.0field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT02345200 nacompletednot on this mapstarted 2013, after this paper: background citation

Body Composition, Muscle Strength and Hormonal Status in Patients With Ataxia Telangiectasia Compared to Healthy Controls

TypeinterventionalSponsorJohann Wolfgang Goethe University HospitalRan2013 to 2014Enrolled52ConditionsAtaxia TelangiectasiaArmsbioelectrical impedance analysis, blood draw
3 · Its place in the literature

Who cites it

245 citing papers in PubMed, 1 synthesis or guideline pooled it, 425 citations in OpenAlex.

  1. Pooled it
  2. Trial
  3. Article
  4. Review
  5. Article
  6. Review
  7. Review
  8. Redox Molecules in Aging and Neurodegenerative Disorders.International journal of molecular sciences · 2026
    Review
  9. Review
  10. Autoinflammatory syndromes of STING and TREX1 dysfunction.The Journal of clinical investigation · 2026
    Review
  11. Review
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Review
  18. Article
  19. DAF-16/FOXO maintains genome integrity following genotoxic stress.bioRxiv : the preprint server for biology · 2025
    Article
  20. Article

185 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 2 institutions in 2 countries.

Claudia CosentinoGenome Stability Unit, Clare Laboratories, London Research Institute, Cancer Research UK, South Mimms, UK.
Domenico Grieco
Vincenzo Costanzo
Cancer Research UK · GBCeinge Biotecnologie Avanzate (Italy) · IT

Funding

Cancer Research UKEuropean Research Council 206281
6 · The paper itself

Abstract

Ataxia telangiectasia (A-T) is a human disease caused by ATM deficiency characterized among other symptoms by radiosensitivity, cancer, sterility, immunodeficiency and neurological defects. ATM controls several aspects of cell cycle and promotes repair of double strand breaks (DSBs). This probably accounts for most of A-T clinical manifestations. However, an impaired response to reactive oxygen species (ROS) might also contribute to A-T pathogenesis. Here, we show that ATM promotes an anti-oxidant response by regulating the pentose phosphate pathway (PPP). ATM activation induces glucose-6-phosphate dehydrogenase (G6PD) activity, the limiting enzyme of the PPP responsible for the production of NADPH, an essential anti-oxidant cofactor. ATM promotes Hsp27 phosphorylation and binding to G6PD, stimulating its activity. We also show that ATM-dependent PPP stimulation increases nucleotide production and that G6PD-deficient cells are impaired for DSB repair. These data suggest that ATM protects cells from ROS accumulation by stimulating NADPH production and promoting the synthesis of nucleotides required for the repair of DSBs.

Indexed as

AnimalsAtaxia Telangiectasia Mutated ProteinsBlotting, WesternCell Cycle ProteinsCells, CulturedComet AssayDNA-Binding ProteinsDNA Breaks, Double-StrandedDNA, ComplementaryDNA RepairGlucosephosphate DehydrogenaseHistonesHSP27 Heat-Shock ProteinsHumansImage Processing, Computer-AssistedImmunoprecipitationAtaxia Telangiectasia Mutated ProteinsATM protein, humanCell Cycle ProteinsDAPIDNA-Binding ProteinsDNA, ComplementaryGlucosephosphate DehydrogenaseH2AX protein, humanHistonesHSP27 Heat-Shock ProteinsIndolesProtein Serine-Threonine KinasesReactive Oxygen SpeciesTumor Suppressor Proteins

Identifiers

PMID21157431
PMCPMC3034007
OpenAlexW2111768081

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-SA
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.